Trial Design Principles for Patients at High Bleeding Risk Undergoing PCI
2020
Capodanno, Davide | Morice, Marie-Claude | Angiolillo, Dominick | Bhatt, Deepak | Byrne, Robert, A | Colleran, Roisin | Cuisset, Thomas | Cutlip, Donald | Eerdmans, Pedro | Eikelboom, John | Farb, Andrew | Gibson, C. Michael | Gregson, John | Haude, Michael | James, Stefan | Kim, Hyo-Soo | Kimura, Takeshi | Konishi, Akihide | Leon, Martin | Magee, P.F. Adrian | Mitsutake, Yoshiaki | Mylotte, Darren | Pocock, Stuart | Rao, Sunil | Spitzer, Ernest | Stockbridge, Norman | Valgimigli, Marco | Varenne, Olivier | Windhovel, Ute | Krucoff, Mitchel | Urban, Philip | Mehran, Roxana | Università degli studi di Catania = University of Catania | Hôpital Privé Jacques Cartier | The University of Florida College of Medicine | Harvard Medical School | Technische Universität Munchen - Technical University Munich - Université Technique de Munich | Département de Cardiologie | Assistance Publique - Hôpitaux de Marseille -Hôpital de la Timone | Centre recherche en CardioVasculaire et Nutrition = Center for CardioVascular and Nutrition research | Aix Marseille Université -Institut National de la Santé et de la Recherche Médicale -Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement | DEKRA CONSULTING GMBH STUTTGART DEU | Partenaires IRSTEA | Institut national de recherche en sciences et technologies pour l'environnement et l'agriculture -Institut national de recherche en sciences et technologies pour l'environnement et l'agriculture | McMaster University
International audience
Show more [+] Less [-]English. Investigating the balance of risk for thrombotic and bleeding events after percutaneous coronary intervention (PCI) is especially relevant for patients at high bleeding risk (HBR). The Academic Research Consortium for HBR recently proposed a consensus definition in an effort to standardize the patient population included in HBR trials. The aim of this consensus-based document, the second initiative from the Academic Research Consortium for HBR, is to propose recommendations to guide the design of clinical trials of devices and drugs in HBR patients undergoing PCI. The authors discuss the designs of trials in HBR patients undergoing PCI and various aspects of trial design specific to HBR patients, including target populations, intervention and control groups, primary and secondary outcomes, and timing of endpoint reporting. (C) 2020 by the American College of Cardiology Foundation.
Show more [+] Less [-]AGROVOC Keywords
Bibliographic information
This bibliographic record has been provided by National Institute for Agricultural Research